APA aipamena

Nagane, M., Kobayashi, K., Saito, K., Shimada, D., Matsumoto, Y., Iijima, S., . . . Shiokawa, Y. (2019). ML-02 MULTIAGENT IMMUNOCHEMOTHERAPY, R-MPV-A, FOR PATIENTS WITH SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA. Neurooncol Adv.

Chicago Style aipamena

Nagane, Motoo, et al. "ML-02 MULTIAGENT IMMUNOCHEMOTHERAPY, R-MPV-A, FOR PATIENTS WITH SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA." Neurooncol Adv 2019.

MLA aipamena

Nagane, Motoo, et al. "ML-02 MULTIAGENT IMMUNOCHEMOTHERAPY, R-MPV-A, FOR PATIENTS WITH SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA." Neurooncol Adv 2019.